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Abstract
Background: Blood of cigarette smokers routinely displays decreased antioxidant capacity and
increased oxidized lipids compared to nonsmokers. This is thought to be due to both chronic
exposure to cigarette smoke in addition to low intake of dietary antioxidants, and is a routine
finding in veteran smokers. No study to date has determined the independent and combined impact
of dietary intake and cigarette smoking on blood antioxidant capacity and oxidative stress in a
sample of young, novice smokers.
Methods: We compared resting plasma antioxidant reducing capacity (ARC; expressed in uric acid
equivalents), serum trolox-equivalent antioxidant capacity (TEAC), whole blood total glutathione,
plasma malondialdehyde (MDA), and plasma oxidized low density lipoprotein (oxLDL) between 15
young (24 ± 4 years), novice smokers (pack-year history: 3 ± 2) and 13 nonsmokers of similar age
(24 ± 5 years). Detailed dietary records were maintained during a seven-day period for analysis of
total energy, macro- and micronutrient intake.
Results: ARC (0.0676 ± 0.0352 vs. 0.1257 ± 0.0542 mmol·L-1; mean ± SD, p = 0.019), TEAC (0.721
± 0.120 vs. 0.765 ± 0.130 mmol·L-1, p = 0.24) and glutathione (835 ± 143 vs. 898 ± 168 μmol·L-1,
p = 0.28) were lower in smokers compared to nonsmokers, with only the former being statistically
significant. MDA (0.919 ± 0.32 vs. 0.647 ± 0.16 μmol·L-1, p = 0.05) and oxLDL were both higher in
smokers compared to nonsmokers (229 ± 94 vs. 110 ± 62 ng·mL-1, p = 0.12), although only the
MDA comparison was of statistical significance. Interestingly, these findings existed despite no
differences in dietary intake, including antioxidant micronutrient consumption, between both
smokers and nonsmokers.
Conclusion: These data, with specificity to young, novice cigarette smokers, underscore the
importance of smoking abstinence. Future studies with larger sample sizes, inclusive of smokers of
different ages and smoking histories, are needed to extend these findings.
Introduction
Production of reactive oxygen species (ROS) in quantities
that overwhelm the endogenous antioxidant defense sys-
tem is referred to as oxidative stress and involves the oxi-
dation of molecules in ways that impair cellular function.
Chronic oxidative stress has a strong association with
numerous disease states including cardiovascular disease
(CVD), with several excellent reviews of associated mech-
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anisms relating oxidative stress with CVD recently pre-
sented [1-4]. Cigarette smokers have an increased risk of
CVD, possibly mediated by elevated levels of oxidized
macromolecules owing to heightened ROS production.
Smokers are exposed to significant quantities of ROS in
both the gas and tar phase [5]. Further ROS production
mediated through inflammatory processes may exacer-
bate those produced through direct exposure [6]. Previous
investigations indicate that smokers have elevated resting
biomarkers of oxidative stress compared to nonsmokers
[7-9]. Subjects in these studies have traditionally been
older, more established smokers, with significant pack-
year histories (>20).
Potential explanations for the elevated levels of oxidative
stress biomarkers in a population of smokers include both
increased ROS production from smoke exposure as well as
an impaired antioxidant defense system. While cigarette
smokers often have lower blood levels of antioxidants
compared to nonsmokers, it remains unclear whether or
not this occurs primarily as a function of decreased dietary
intake of antioxidant rich foods [10-13] or depletion of
circulating antioxidants through chronic smoke exposure
[14,15]. The few studies that controlled for dietary levels
of isolated antioxidant nutrients as reviewed by Alberg
[14] have suggested that smoking may independently lead
to selective depletion in blood levels of the nutrient of
focus. Unfortunately, these investigations have not con-
sidered "total" antioxidant capacity, rather focusing on
vitamin C or the carotenoids, while many investigations
have simply failed to control for dietary factors altogether.
Moreover, while blood antioxidant capacity is important,
the oxidation of molecules that may contribute to disease,
such as low density lipoprotein (LDL), appears most
important. Lastly, in the one study that has measured
multiple antioxidant vitamins in relation to smoking and
dietary intake [15], subjects were older (mean age of 43
years) and more established smokers (mean pack-year
history of 27). Therefore, the purpose of this investigation
was to determine the independent and combined effect of
cigarette smoke exposure and dietary antioxidant intake
on blood antioxidant capacity and lipid peroxidation, and
to do so in a population of young, novice smokers. It was
found that young, novice smokers (pack-year history of 3
± 4) have lower blood antioxidant capacity and greater
lipid peroxidation compared to nonsmokers, despite hav-
ing similar dietary intake.
Methods
Participants
Fifteen cigarette smokers and 13 nonsmokers volunteered
to participate in this investigation. During an initial
screening visit, participants completed a health history
questionnaire and underwent a physical examination. All
participants were sedentary and free of major signs and
symptoms suggestive of cardiovascular and pulmonary
disease. No participant used nutritional supplements
(e.g., antioxidants) or medications (e.g., anti-inflamma-
tory or cardiovascular drugs) that may have affected the
dependent variables being measured. Participants needed
to regularly smoke ≥5 cigarettes per day to be enrolled as
a smoker and needed to be smoking continuously for a
minimum of six months prior to being enrolled. Non-
smokers were those participants who had never smoked
based on self report, and were not routinely exposed to
environmental tobacco smoke in social situations. All
experimental procedures were in compliance with the
Helsinki Declaration and approved by the University
Human Subjects Review Board and participants provided
both verbal and written consent prior to participating.
Participant characteristics are presented in Table 1.
Blood collection and biochemistry
Approximately one week following the initial screening
visit, participants reported to the laboratory in a fasted
state. Smokers were instructed to refrain from smoking for
the one hour period prior to reporting to the lab as previ-
ously suggested by Dietrich et al. [15]. Venous blood sam-
ples were collected via needle and vacutainer following a
10-minute quiet rest period. A portion of whole blood
was deproteinated using 5% metaphosphoric acid and
then assayed for total glutathione using commercially
available reagents (Northwest Life Science Specialties,
Vancouver, WA). The remainder of whole blood was sep-
arated immediately to plasma or serum and stored in mul-
tiple aliquots at -80°C. Plasma antioxidant reducing
capacity (ARC; represented as uric acid equivalents) was
determined as a measure of blood antioxidant capacity
using commercially available reagents (Northwest Life
Science Specialties, Vancouver, WA). Serum trolox-equiv-
alent antioxidant capacity (TEAC) was determined using
Table 1: Characteristics of smokers and nonsmokers.
Variable Smokers (n = 15) Nonsmokers (n = 13)
Age (yrs) 24 ± 4 24 ± 5
Height (cm) 173 ± 8 172 ± 8
Weight (kg) 81 ± 14 77 ± 15
BMI (kg·m-2)2 6 . 7  ±  4 2 5 . 5  ±  3
Resting Heart Rate (bpm) 70 ± 3 67 ± 3
Resting SBP (mmHg) 120 ± 12 116 ± 10
Resting DBP (mmHg) 78 ± 10 74 ± 10
Cigarettes per day 11 ± 10 NA
Years smoking 6 ± 5 NA
Pack-Years 3 ± 4 NA
Note: Values are mean ± SD. No statistical differences were noted 
between groups for any of the above variables (p > 0.05). BMI, body 
mass index; SBP, systolic blood pressure; DBP, diastolic blood 
pressure.Nutrition Journal 2007, 6:39 http://www.nutritionj.com/content/6/1/39
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procedures outlined by the reagent provided (Sigma
Chemical, St. Louis, MO). Malondialdehyde (MDA) was
analyzed in plasma using the method described by
Jentzsch et al. [16]. Plasma oxidized LDL (oxLDL) was
determined using an enzyme linked immunosorbent
assay (ELISA) procedure (Alpco Diagnostics, Salem, NH).
Both MDA and oxLDL were used as markers of lipid per-
oxidation. Assays were performed in duplicate on first
thaw.
Dietary records
In order to compare dietary intake between smokers and
nonsmokers, detailed diet records were maintained by all
participants for the seven days prior to providing their
blood sample. During the period of recording, partici-
pants were instructed to record all food and drink con-
sumed, and were strongly encouraged to consume their
normal diets. Using standardized procedures for dietary
data collection that our unit has used for several years
[17,18], participants were provided with written instruc-
tions on how to complete the food records in addition to
personal instruction during their screening visit. Upon
return of records, each entry was reviewed with partici-
pants to assure accuracy. Although the necessity for thor-
ough descriptions by the participant and detailed review
by the researchers has been questioned [19], we chose to
continue with this protocol until more definitive data
appear. These procedures, as well as dietary data entry and
management, were overseen by the same research assist-
ant. Records were analyzed for total kilocalories, protein,
carbohydrate, fat, vitamin C, vitamin E, vitamin A, B vita-
mins, and selected minerals using commercially available
software (Diet Analysis Plus, ESHA Research, Salem, OR).
This analysis allowed for nutrient intake assessment
between smokers and nonsmokers.
Statistical analysis
All data were compared between smokers and nonsmok-
ers using a one-way ANOVA. Effect size calculations for all
bloodborne variables were performed using Cohen's D.
Regression analysis for the each dependent variable (e.g.,
glutathione, ARC, TEAC, MDA, and oxLDL) was per-
formed using the following predictor variables: smoking
status (smoker/nonsmoker), vitamin C, vitamin A, vita-
min E. These antioxidant nutrients were chosen as they
have been reported previously to be impacted by cigarette
smoke, as well as alter levels of oxidative stress and anti-
oxidant biomarkers. The distribution of data for each pre-
dictor was checked for normality prior to inclusion.
Pairwise correlations were performed on all predictor var-
iables in order to determine multi-collinearity. If correla-
tions above 0.90 were observed between predictor
variables, only the variable with the higher R2 values was
included. None of the predictor variables needed to be
excluded for this reason. Following these steps, block
regression using smoking status and dietary antioxidant
intake (vitamin C, vitamin A, vitamin E; as one block) was
performed. In a separate analysis, smoking history based
on the number of cigarettes smoked per day and the
number of years smoked were included as independent
predictors of the bloodborne variables. All analyses were
performed using JMP statistical software version 4.0 (SAS
Institute, Cary, NC). Statistical significance was set at p <
0.05. The data are presented as mean ± SD.
Results
Antioxidant reducing capacity was lower (p = 0.019) and
MDA was higher in smokers compared to nonsmokers (p
= 0.05). Total glutathione (p = 0.28) and TEAC (p = 0.24)
were not statistically different between smokers and non-
smokers, although were both slightly lower for smokers.
Results for oxLDL approached statistical significance (p =
0.12) and oxLDL was more than two-fold higher in smok-
ers compared to nonsmokers. Effect size calculations for
ARC, MDA, and oxLDL were considered to be moderate.
Data for all bloodborne variables are presented in Table 2.
Dietary intake for smokers and nonsmokers was not sta-
tistically different for total kilocalories, macronutrients or
micronutrients (p > 0.05, Table 3). Regression analysis
indicated that the classification of smoker (smoker or
nonsmoker) contributed to the greatest percentage of the
variability in ARC (R2 = 0.22), MDA (R2 = 0.31), and oxi-
dized LDL (R2 = 0.11) when compared to individual die-
tary components. This was accounted for primarily by the
number of years smoking as opposed to the number of
cigarettes smoked per day. For example, within smokers it
was noted that the number of years smoking accounted
Table 2: Bloodborne variables for smokers and nonsmokers.
Variable Smokers (n = 15) Nonsmokers (n = 13) P value Effect Size
Antioxidant Reducing Capacity (mmol·L-1) 0.0676 ± 0.0352 0.1257 ± 0.0542 0.019* 0.54
Trolox-Equivalent Antioxidant Capacity (mmol·L-1) 0.721 ± 0.120 0.765 ± 0.130 0.24 0.17
Total Glutathione (μmol·L-1) 835 ± 143 898 ± 168 0.28 0.20
Malondialdehyde (μmol·L-1) 0.919 ± 0.32 0.647 ± 0.16 0.05* 0.47
Oxidized Low Density Lipoprotein (ng·mL-1) 229 ± 94 110 ± 62 0.12 0.60
Note: Values are mean ± SD.Nutrition Journal 2007, 6:39 http://www.nutritionj.com/content/6/1/39
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for the greatest variability in ARC (R2 = 0.26) and MDA
(R2 = 0.22), although less variability was explained by this
regressor in oxLDL (R2 = 0.12), glutathione (R2 = 0.04),
and TEAC (R2 = 0.08). The number of cigarettes smoked
per day did not explain a large portion of the variability in
any of the dependent variables. Multiple regression with
the addition of vitamins C, A, and E (as one block)
increased the R2 to 0.33 for ARC, to 0.41 for MDA, and to
0.22 for oxLDL. Smoking and dietary intake contributed
little to explaining the variability in total blood glutath-
ione and TEAC.
Discussion
Data from the present study indicate that young, novice
smokers (pack-year history of 3 ± 4) have a lower plasma
antioxidant capacity and exhibit a greater degree of lipid
peroxidation compared to nonsmokers, despite having
similar dietary intake. These data suggest that the act of
cigarette smoking may independently promote such neg-
ative changes, with the number of years spent smoking
contributing most to these findings. While dietary intake,
as well as other genetic and environmental factors not
determined in this investigation may contribute to these
results, it appears that smoking plays a major role in pro-
moting these changes.
It is known that exogenous antioxidant intake from whole
food and nutritional supplements may influence both the
antioxidant capacity of blood [20] as well as oxidative
stress biomarkers [21]. It has been independently
reported that smokers consume less antioxidant rich
foods compared to nonsmokers [11-13] and have sup-
pressed blood levels of certain antioxidants such as ascor-
bic acid [15], tocopherol, and superoxide dismutase [22],
which may influence the degree of oxidative stress. As
such, many investigators have reported elevated levels of
oxidative stress biomarkers in smokers compared to non-
smokers [7-9]. However, no previous study has deter-
mined the independent and combined contribution of
smoking and dietary antioxidant intake on blood antioxi-
dant capacity and oxidative stress biomarkers, in particu-
lar within a population of young, novice smokers.
Previous studies have included older, more established
smokers, as in the work of Dietrich and coworkers [15] in
which subjects had a mean age of 43 years and a mean
pack history of 27 years. In contrast, our participants had
a mean age of 24 years and a mean pack history of only 3
years. While these findings are interesting, they are highly
specific to young, novice smokers. Future studies with
larger sample sizes, inclusive of smokers of different ages
and smoking histories, are needed to extend these find-
ings. In this way, smokers could be classified by age, as
well by smoking habit (e.g., light, moderate, and heavy).
Using this approach, data would better be able to be gen-
eralized to the population at large.
We chose to measure blood antioxidant capacity as well as
two common markers of lipid peroxidation, MDA and
oxLDL. A great deal of focus has been placed on the oxida-
tive modification of lipids, and in particular LDL and the
causal role of oxLDL in the pathophysiology of atheroscle-
rosis [23,24]. Oxidized LDL is more atherogenic than
native LDL and is taken up by the scavenger receptor sys-
tem ultimately leading to the generation of foam cells and
the development of early lesions [25]. Atherosclerotic
lesions in both animal and man have been reported to
contain significant oxLDL [26], while antibodies to oxLDL
have been found to correlate with the progression of
atherosclerosis [27]. Oxidized LDL is also cytotoxic and
has the ability to promote endothelial dysfunction, as
well as the induction of genes such as interleukin-1 that
can induce smooth muscle cell proliferation and promote
a procoagulant state [28]. Furthermore, oxLDL may pro-
mote platelet adhesion, trigger DNA strand breaks, and
promote apoptosis, all of which contribute to the devel-
opment of atherosclerotic disease [29]. Based on the
above, we believe that oxLDL is an important marker to
focus on in relation to oxidative stress research. Although
we failed to note statistical significance between smokers
and nonsmokers with regards to oxLDL, values were more
than two-fold higher in smokers and our effect size calcu-
lation for this marker was moderate. It is likely that we
were underpowered statistically to detect significance in
oxLDL. Future studies with larger samples are needed to
corroborate our findings.
Table 3: Dietary intake during the seven days prior to providing blood sample for smokers and nonsmokers.
Participants Kcal Protein Carbohydrate Fat Vitamin C Vitamin E Vitamin A Iron
Smokers 1850 ± 666 65 ± 20
(18 ± 8)
242 ± 85 
(51 ± 8)
66 ± 28 
(31 ± 4)
37 ± 20 4 ± 2 667 ± 387 14 ± 5
Nonsmokers 1643 ± 302 61 ± 19 
(15 ± 4)
214 ± 55 
(52 ± 10)
60 ± 20 
(33 ± 8)
54 ± 47 5 ± 3 499 ± 548 12 ± 7
Note: Data are mean ± SD. Gram quantities for each macronutrient are provided with corresponding percentages in parentheses. Vitamin C, 
vitamin E, and iron values are provided in mg; vitamin A values are provided in retinol equivalents. No statistical differences were noted between 
groups for any measured variable shown above or for any of the B vitamins, vitamin D, calcium, sodium, potassium, phosphorous, or zinc (p > 0.05).Nutrition Journal 2007, 6:39 http://www.nutritionj.com/content/6/1/39
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It should be noted that despite no differences in dietary
variables between smokers and nonsmokers, mean vita-
min C, vitamin E, and vitamin A intake was lower than the
recommended Dietary Reference Intakes for both groups
of participants. The current recommended daily intake of
vitamin C is 75 mg per day for women and 90 mg per day
for men 19–50 years of age. Daily vitamin E intake is sug-
gested at 15 mg per day for both men and women, while
vitamin A intake is suggested at 700 μg per day for women
and 900 μg per day for men 19–50 years of age. It is pos-
sible that the lower than recommended intake of these
vitamins could have promoted a lower antioxidant capac-
ity and higher lipid peroxidation. However, because we
found no statistical difference between groups for these
variables, we have no reason to believe that one group was
affected more than another in this regard. While partici-
pants were instructed to record all food and drink con-
sumed during the reporting period, it is possible that
underreporting could have occurred. If so, the analyzed
values may have been lower than what participants habit-
ually consume. This is indeed a limitation of the present
investigation and of using dietary records within a free liv-
ing environment to determine nutrient intake.
Conclusion
These findings indicate that young, novice cigarette smok-
ers have lower blood antioxidant capacity and higher lipid
peroxidation levels compared to nonsmokers, despite
having similar dietary intake. This is the first report to sug-
gest that the act of cigarette smoking, in particular the
number of years participating in this activity, may mani-
fest in impaired antioxidant capacity and elevated oxida-
tive stress independent of dietary intake. In particular,
these data are in reference to young, novice smokers. It is
very possible that more robust findings in relation to
nutrient intake would be observed in a population of
older, more established smokers. Future study is needed
to confirm this hypothesis. Based on previous literature,
such changes over time appear to have the potential to
promote ill-health and disease within susceptible individ-
uals. Additional studies using larger samples with the
inclusion of clinically relevant endpoints are needed to
extend these findings.
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